(Q36831149)

16 August 2017

1 reference

title

How do we improve outcomes for gastric cancer? (English)

1 reference

16 August 2017

Khay-Guan Yeoh

1

1 reference

16 August 2017

publication date

24 May 2007

1 reference

Journal of Gastroenterology and Hepatology

16 August 2017

published in

1 reference

16 August 2017

volume

22

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

970-972

1 reference

The long term results of endoscopic surveillance of premalignant gastric lesions

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

New diagnostic approaches for early detection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Diagnosis of gastric cancer by serum proteomic fingerprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

The time to eradicate gastric cancer is now

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Current status of surgery for gastric cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Current status and future prospects of chemotherapy for metastatic gastric cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Molecular basis of gastric cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

1'-acetoxychavicol acetate is a novel nuclear factor kappaB inhibitor with significant activity against multiple myeloma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04956.X

10.1111/J.1440-1746.2007.04956.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference